I am in strong support of S. 1789, the Best Pharmaceuticals for Children Act; and I want to congratulate the sponsor of the bill, the gentleman from Pennsylvania (Mr. Greenwood), and the gentlewoman from California (Ms. Eshoo) for working on crafting this legislation, which is important. It is a much-needed piece of legislation. It creates an incentive for pharmaceutical companies to conduct pediatric studies to increase pediatric information. Children are subject to many of the same diseases as adults and, by necessity, are often treated with the same drugs. According to the American Academy of Pediatrics, only a small fraction of all drugs marketed in the United States has been studied in pediatric patients; and a majority of marketed drugs are not labeled or are insufficiently labeled for use in pediatric patients. Safety and effectiveness information for the youngest pediatric age groups is particularly difficult to find in product labeling.
Editor's note · Context
Supporting the Best Pharmaceuticals for Children Act during a House floor debate.
Share
More from Connie Morella
I don't have a hat on, so you can see me, can't you. I thank you, Tim. What I will be mentioning to you is going to be a long list of businesses and countries that have been affiliated with us. It will show you how extensive, how…
Fellow association members, I'm very pleased again to welcome you to our 42nd annual meeting. And I'd like to tell you something about the association. It is bipartisan, as you know. It was chartered by Congress in 1983. The purpose of the…
Mr. Kolbe, if I may read it. It is very small print. The plaque is inscribed as follows: The 2012 Distinguished Service Award is presented by the U.S. Association of Former Members of Congress to Congresswoman Gabrielle ``Gabby'' Giffords…
Thank you, Jim. All the programs that we have described of course require both leadership and staff to implement, and I want to say openly and very enthusiastically our association is blessed to have top people in both categories. I want…





